This advanced test evaluates risk factors for cardiovascular disease (CVD) plus metabolic factors associated with metabolic syndrome and type II diabetes.  In addition to the traditional CVD risk factors, the test includes much more clinically sensitive atherogenic lipoprotein sub-species, the primary apolipoproteins, arterial inflammation and the activity of the lipoprotein- associated phospholipase- A2 (PLAC^®).  PLAC^® activity is a very sensitive indicator of active atherogenesis and instability of advanced arterial plaque.  Metabolic syndrome (MetS) is centered around insulin resistance and atherogenic dyslipoproteinemia, and is a risk factor associated with CVD and kidney disease. The test includes cystatin C to better assess glomerular filtration, and 1,5-anhydroglucitol (Glycomark^®) that is a better indicator of hyperglycemic episodes than HbA1C.  The primary adipokines associated with insulin sensitivity and hepatic fatty acid metabolism are also addressed.

Useful for:

• Family or personal history of CVD
• Excess abdominal fat
• Obesity
• Insulin resistance
• Fatty liver disease

Turnaround Time

5 to 7 days

Note: Turnaround times on results are an estimate and are not guaranteed. The lab may need additional time due to holidays, confirmation/repeat testing, etc. You can contact us to discuss when your results should be ready.

Analytes Tested

• Cystatin C; serum
• Leptin; serum
• Adiponectin; serum
• Leptin : Adiponectin ratio
• Apolipoprotein, A1; serum
• Apolipoprotein, B, serum
• C-Reactive Protein; serum
• Creatinine; serum with eGFR
• Glucose; serum
• Glycomark (1,5-AG); serum
• HDL Cholesterol; serum
• Homocysteine; serum
• Insulin; serum
• LDL Cholesterol; calculated
• Lipoprotein (a), serum
• Non-HDL Cholesterol; calculated
• Oxidized LDL; serum
• PLAC (LP-PLA2 Activity); serum
• Small dense LDL Cholesterol; calculated
• Total Cholesterol; serum
• Triglycerides; serum
• VLDL Cholesterol; calculated